Novo Nordisk is seen as having fallen behind in the race for new obesity drugs. It argues it is playing the long game.

Americans with obesity face almost double the financial hardship as their peers without obesity, according to a study published in Annals of Internal Medicine that highlighted not ...

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...

The latest news and headlines from Yahoo News. Get breaking news stories and in-depth coverage with videos and photos.